Drugs / CIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01758679 | Jan 2012 → Nov 2016 | — | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01758679 ↗ |
| Modality | Cell therapy | “CIK cell” NCT01758679 ↗ |